Bharat Parenterals
BPLPHARMANSE

Bharat Parenterals

₹1,397.10102.40 (7.91%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
1,331.00
Today’s high
1,528.90
52 week low
1,125.70
52 week high
1,619.00
Open price
1,528.90
Previous close
1,294.70
Live volume
4,535
Lower circuit
1,035.80
Upper circuit
1,553.60

Fundamentals

Market Cap
₹923Cr
ROE
-2.54%
P/E Ratio(TTM)
--
EPS(TTM)
-43.52
P/B Ratio
2.86
Dividend Yield
0.07%
Industry P/E
37.23
Book Value
467.55
Debt to Equity
0.45
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
JUN '26
Revenue (Cr)
₹94.85
-8.14%
Profit (Cr)
-₹3.56
+56.37%
-50050100150
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)-19%
3Y CAGR+17%
Profit growthValue
1Y (TTM)-76%

About

Bharat Parenterals Limited is a public company based in India, specializing in the manufacturing of diverse pharmaceutical formulations for a global customer base. The company envisions becoming a leading manufacturer of formulations by harnessing its strong resource base to meet industry challenges and seize growth opportunities ahead. Through its Corporate Social Responsibility policy, the company encourages a strong commitment from the organization and employees to address the healthcare challenges of the country. Its core business is centered on the manufacturing and marketing of drug formulations, supported by research and development to ensure cost-competitiveness and regulatory compliance. The company's strategy involves the continual expansion of its product lines and customer base by systematically reinforcing its quality, innovation, and cost-efficiency. With a WHO-cGMP certified modern production facility and over 500 formulations, the company conforms to international standards and has established a global export footprint.;
CEO/MD
Bharat Desai
Founded in
1992
NSE symbol
BPLPHARMA

Shareholding pattern

Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
PfizerPFIZER
₹4,978.20
+58.20 (1.18%)
L
    H
    22,514.2930.625.36
    ₹2,560.80
    +31.10 (1.23%)
    L
      H
      19,234.0028.375.36
      ₹7,415.50
      -91.50 (1.22%)
      L
        H
        18,760.75110.621.5
        Natco PharmaNATCOPHARM
        ₹882.40
        +4.90 (0.56%)
        L
          H
          15,721.3713.731.7
          Livesquawk
          Bharat Parenterals reported Q1 EBITDA of ₹138M YoY. Q1 EBITDA margin stood at 11.9% YoY for Bharat Parenterals.
          2026
          5
          Aug
          Quarterly Result
          Release date
          18
          May
          Quarterly & Annual Result
          Release date
          30
          Jan
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date

          19
          Sep
          Dividend
          Ex date
          ₹1.00
          per share

          For each share you hold, you will receive ₹1.00
          Dividend amount₹1.00 per share
          Dividend TypeFinal
          Ex Date19 Sep ‘25
          Record Date19 Sep ‘25
          Announcement date12 May ‘25
          28
          Jul
          Quarterly Result
          Release date

          12
          May
          Dividend
          Announced
          ₹1.00
          per share

          For each share you hold, you will receive ₹1.00
          Dividend amount₹1.00 per share
          Dividend TypeFinal
          Ex Date19 Sep ‘25
          Record Date19 Sep ‘25
          Announcement date12 May ‘25
          Events calendar
          View upcoming events in other stocks